Abstract:OBJECTIVE:To evaluate the association between homocysteine level and prethrombotic status and long-term thromboembolic events in patients with primary hypertension.METHODS:Results between 110 hypertensive patients with elevated homocysteine (HCY) level were compared with 110 hypertensive patients with normal HCY level which were enrolled from October 2003 to November 2009. Fibrinogen (FIB), viscosity, thrombomodulin (TM), granule membrane protein (GMP-140), prethrombin F1+2 fragment (F1+2), D-dimer fragment (D-Dimer) and antithrombin III (AT-III) were measured and correlated to HCY and prethrombotic state. The endpoints of the study were arterial and venous thromboembolic events. The variables linked with arterial and venous thromboembolic events were included in Cox proportional hazard models. The event-free survival was illustrated with Kaplan-Meier survival curves and compared by the Log-rank test.RESULTS:The patients were followed up for 8-122 months (median follow-up time was 85 months). Compared with hypertensive patients with normal HCY, the plasma level of TM ((4.8±1.2) µg/L vs. (4.5±1.0) µg/L, P = 0.045), GMP-140 ((18.8±3.2) µg/L vs. (17.1±4.3) µg/L, P = 0.001), F1+2 ((1.2±0.4) nmol/L vs. (1.0±0.6) nmol/L, P = 0.004) were significantly higher while the plasma level of AT-III ((95.3±10.4) % vs. (98.6±10.6)%, P = 0.021) was significantly lower in hypertensive patients with elevated HCY level. FIB, viscosity of plasma and D-dimer were similar between the two groups. Multiple regression analyses indicated that HCY level was negatively correlated with AT-III (β = -0.199, P = 0.011) and positively correlated with age (β = 0.217, P = 0.04), female gender (β = 5.667, P = 0.001) and TM (β = 2.341, P = 0.003). Cox multivariate analysis revealed that age and HCY level were independent prognostic risk factors of thromboembolic events (OR 1.046, 95% CI 1.013-1.082, OR 1.052, 95% CI 1.027-1.078, respectively) (all P < 0.05). Kaplan-Meier curves showed that there was a significant difference in the event-free survival between the two groups (Log-rank test, P = 0.027).CONCLUSIONS:Compared with normal HCY hypertensive patients, the levels of plasma prothrombin activators such as TM, GMP-140 and F1+2 were significant increased and anti-thrombin factor such as AT-III was significant decreased in hypertensive patients with elevated HCY. Old age and high HCY level were independent prognostic risk factors of thromboembolic events. The event-free survival in hypertensive patients with elevated HCY is lower than in hypertensive patients with normal HCY level.

[Prethrombotic Status and Long-Time Thromboembolic Events in Primary Hypertensive Patients with or Without Elevated Homocysteine Level].

Clinical Significance of Plasma Homocysteine in the Coronary Atherosclerosis Patients

The Relationship of Homocysteine Levels to Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Acute Coronary Syndrome Patients

Prevalence of Hyperhomocysteinemia (hhcy) and Its Major Determinants among Hypertensive Patients over 35 Years of Age.

Analysis of correlation between plasma homocysteine and target organ damage and complications in hypertension patients

Intermediate-Term Prognostic Value of Homocysteine in Acute Coronary Syndrome Complicated with or without Hypertension: A Multicenter Observational Cohort Study

A13501 Study on Correlation Between Plasma Homocysteinemia Level and Target Organ Damage in Patients with Primary Hypertension

Acute Phase Homocysteine Related to Severity and Outcome of Atherothrombotic Stroke.

Value of Plasma Homocysteine to Predict Stroke, Cardiovascular Diseases, and New-Onset Hypertension

Changes and correlation study of plasma homocysteine in patients with primary hypertension

Hyperhomocysteinemia and Hyperlipidemia in Coronary Heart Disease.

The Association Between Total Homocysteine and Blood Pressure in Two Independent Chinese Populations.

[Association Between Plasma Homocysteine Level and Hyperuricemia in Elderly Patients With Hypertension].

Association of Homocysteine with Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients

Homocysteine and fibrinolysin in elderly patients with coronary heart disease

A6282 Association of Homocysteine with Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients

Relationship Between Plasma Homocysteine Levels and Severity of Coronary Heart Disease

Homocysteine, Ischemic Stroke, and Coronary Heart Disease in Hypertensive Patients

Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension: A double-blinded, randomized clinical cohort study

High Plasma Homocysteine Levels Contribute to the Risk of Stroke Recurrence and All-Cause Mortality in a Large Prospective Stroke Population.

Associations of Homocysteine Status and Homocysteine Metabolism Enzyme Polymorphisms with Hypertension and Dyslipidemia in a Chinese Hypertensive Population.